News | October 16, 2025
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
EDQM has also issued a Certificate of Suitability for Allopurino
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
This will be an added advantage for Supriya Lifescience Limited in the European market.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Subscribe To Our Newsletter & Stay Updated
